Ellsworth Advisors »

Neurocrine Biosciences shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.8M 40k 172.05

More positions owned by Ellsworth Advisors

Harbor Etf Trust Comm All Wea Etf (HGER)
Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Apple (AAPL)
First Tr Exchange-traded First Tr Enh New (FTSM)
Dell Technologies CL C (DELL)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Goldman Sachs (GS)
Cisco Systems (CSCO)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Enterprise Products Partners (EPD)

View all positions for Ellsworth Advisors

Top funds holding Neurocrine Biosciences

BlackRock
Dodge & Cox
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Bnp Paribas Investment Partners
Wellington Management Company
Vestal Point Capital
Millennium Management
Northern Trust
UBS Group

View all funds holding Neurocrine Biosciences